A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

Clinical trial NCT02373072 · COMPLETED

Trial details

NCT number: NCT02373072
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Parkinson Disease

Start date: 2015-03-01
Primary completion: 2016-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.